Keywords
Last Name
Institution

James C. Ballenger

Title
InstitutionMedical University of South Carolina
DepartmentPsychiatry and Behavioral Sciences
Address
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. George MS, Ward HE, Ninan PT, Pollack M, Nahas Z, Anderson B, Kose S, Howland RH, Goodman WK, Ballenger JC. A pilot study of vagus nerve stimulation (VNS) for treatment-resistant anxiety disorders. Brain Stimul. 2008 Apr; 1(2):112-21. PMID: 20633378.
      View in: PubMed
    2. Post RM, Ketter TA, Uhde T, Ballenger JC. Thirty years of clinical experience with carbamazepine in the treatment of bipolar illness: principles and practice. CNS Drugs. 2007; 21(1):47-71. PMID: 17190529.
      View in: PubMed
    3. Weisler RH, Cutler AJ, Ballenger JC, Post RM, Ketter TA. The use of antiepileptic drugs in bipolar disorders: a review based on evidence from controlled trials. CNS Spectr. 2006 Oct; 11(10):788-99. PMID: 17008822.
      View in: PubMed
    4. Lorberbaum JP, Kose S, Johnson MR, Arana GW, Sullivan LK, Hamner MB, Ballenger JC, Lydiard RB, Brodrick PS, Bohning DE, George MS. Neural correlates of speech anticipatory anxiety in generalized social phobia. Neuroreport. 2004 Dec 22; 15(18):2701-5. PMID: 15597038.
      View in: PubMed
    5. Ballenger JC. Remission rates in patients with anxiety disorders treated with paroxetine. J Clin Psychiatry. 2004 Dec; 65(12):1696-707. PMID: 15641876.
      View in: PubMed
    6. Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Marshall RD, Nemeroff CB, Shalev AY, Yehuda R. Consensus statement update on posttraumatic stress disorder from the international consensus group on depression and anxiety. J Clin Psychiatry. 2004; 65 Suppl 1:55-62. PMID: 14728098.
      View in: PubMed
    7. Roy-Byrne P, Russo J, Pollack M, Stewart R, Bystrisky A, Bell J, Rosenbaum J, Corrigan MH, Stolk J, Rush AJ, Ballenger J. Personality and symptom sensitivity predictors of alprazolam withdrawal in panic disorder. Psychol Med. 2003 Apr; 33(3):511-8. PMID: 12701671.
      View in: PubMed
    8. Simon NM, Emmanuel N, Ballenger J, Worthington JJ, Kinrys G, Korbly NB, Farach FJ, Pollack MH. Bupropion sustained release for panic disorder. Psychopharmacol Bull. 2003; 37(4):66-72. PMID: 15131517.
      View in: PubMed
    9. Nutt DJ, Ballenger JC, Sheehan D, Wittchen HU. Generalized anxiety disorder: comorbidity, comparative biology and treatment. Int J Neuropsychopharmacol. 2002 Dec; 5(4):315-25. PMID: 12466031.
      View in: PubMed
    10. Malcolm R, Myrick H, Roberts J, Wang W, Anton RF, Ballenger JC. The effects of carbamazepine and lorazepam on single versus multiple previous alcohol withdrawals in an outpatient randomized trial. J Gen Intern Med. 2002 May; 17(5):349-55. PMID: 12047731.
      View in: PubMed
    11. Pellegrin KL, Stuart GW, Maree B, Frueh BC, Ballenger JC. A brief scale for assessing patients' satisfaction with care in outpatient psychiatric services. Psychiatr Serv. 2001 Jun; 52(6):816-9. PMID: 11376232.
      View in: PubMed
    12. Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ. A Proposed Algorithm for Improved Recognition and Treatment of the Depression/Anxiety Spectrum in Primary Care. Prim Care Companion J Clin Psychiatry. 2001 Apr; 3(2):44-52. PMID: 15014615.
      View in: PubMed
    13. Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Roose SP, Sheps DS. Consensus statement on depression, anxiety, and cardiovascular disease. J Clin Psychiatry. 2001; 62 Suppl 8:24-7. PMID: 12108818.
      View in: PubMed
    14. Ballenger JC. Treatment of anxiety disorders to remission. J Clin Psychiatry. 2001; 62 Suppl 12:5-9. PMID: 11430617.
      View in: PubMed
    15. Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Kirmayer LJ, Lépine JP, Lin KM, Tajima O, Ono Y. Consensus statement on transcultural issues in depression and anxiety from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry. 2001; 62 Suppl 13:47-55. PMID: 11434419.
      View in: PubMed
    16. Malcolm R, Myrick H, Brady KT, Ballenger JC. Update on anticonvulsants for the treatment of alcohol withdrawal. Am J Addict. 2001; 10(s1):s16-s23. PMID: 11268817.
      View in: PubMed
    17. Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Borkovec TD, Rickels K, Stein DJ, Wittchen HU. Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry. 2001; 62 Suppl 11:53-8. PMID: 11414552.
      View in: PubMed
    18. Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Lydiard RB, Mayer EA. Consensus statement on depression, anxiety, and functional gastrointestinal disorders. J Clin Psychiatry. 2001; 62 Suppl 8:48-51. PMID: 12108822.
      View in: PubMed
    19. Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Jones RD, Berard RM. Consensus statement on depression, anxiety, and oncology. J Clin Psychiatry. 2001; 62 Suppl 8:64-7. PMID: 12108825.
      View in: PubMed
    20. Ballenger JC. Overview of different pharmacotherapies for attaining remission in generalized anxiety disorder. J Clin Psychiatry. 2001; 62 Suppl 19:11-9. PMID: 11577786.
      View in: PubMed
    21. Ballenger JC. Structural issues and policy in the management of depressive illness. Overview and expert panel commentary. Eur Neuropsychopharmacol. 2000 Dec; 10 Suppl 4:S449-53. PMID: 11114491.
      View in: PubMed
    22. George MS, Sackeim HA, Marangell LB, Husain MM, Nahas Z, Lisanby SH, Ballenger JC, Rush AJ. Vagus nerve stimulation. A potential therapy for resistant depression? Psychiatr Clin North Am. 2000 Dec; 23(4):757-83. PMID: 11147246.
      View in: PubMed
    23. Frueh BC, Deitsch SE, Santos AB, Gold PB, Johnson MR, Meisler N, Magruder KM, Ballenger JC. Procedural and methodological issues in telepsychiatry research and program development. Psychiatr Serv. 2000 Dec; 51(12):1522-7. PMID: 11097648.
      View in: PubMed
    24. George MS, Nahas Z, Molloy M, Speer AM, Oliver NC, Li XB, Arana GW, Risch SC, Ballenger JC. A controlled trial of daily left prefrontal cortex TMS for treating depression. Biol Psychiatry. 2000 Nov 15; 48(10):962-70. PMID: 11082469.
      View in: PubMed
    25. George MS, Nahas Z, Bohning DE, Lomarev M, Denslow S, Osenbach R, Ballenger JC. Vagus nerve stimulation: a new form of therapeutic brain stimulation. CNS Spectr. 2000 Nov; 5(11):43-52. PMID: 18188148.
      View in: PubMed
    26. Ballenger JC. Recognizing the patient with social anxiety disorder. Int Clin Psychopharmacol. 2000 Jul; 15 Suppl 1:S1-5. PMID: 10994676.
      View in: PubMed
    27. Ballenger JC. Anxiety and Depression: Optimizing Treatments. Prim Care Companion J Clin Psychiatry. 2000 Jun; 2(3):71-79. PMID: 15014652.
      View in: PubMed
    28. George MS, Sackeim HA, Rush AJ, Marangell LB, Nahas Z, Husain MM, Lisanby S, Burt T, Goldman J, Ballenger JC. Vagus nerve stimulation: a new tool for brain research and therapy. Biol Psychiatry. 2000 Feb 15; 47(4):287-95. PMID: 10686263.
      View in: PubMed
    29. Emmanuel NP, Brawman-Mintzer O, Morton WA, Book SW, Johnson MR, Lorberbaum JP, Ballenger JC, Lydiard RB. Bupropion-SR in treatment of social phobia. Depress Anxiety. 2000; 12(2):111-3. PMID: 11091936.
      View in: PubMed
    30. Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Foa EB, Kessler RC, McFarlane AC, Shalev AY. Consensus statement on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry. 2000; 61 Suppl 5:60-6. PMID: 10761680.
      View in: PubMed
    31. Ballenger JC. Current treatments of the anxiety disorders in adults. Biol Psychiatry. 1999 Dec 01; 46(11):1579-94. PMID: 10599485.
      View in: PubMed
    32. Greenberg PE, Sisitsky T, Kessler RC, Finkelstein SN, Berndt ER, Davidson JR, Ballenger JC, Fyer AJ. The economic burden of anxiety disorders in the 1990s. J Clin Psychiatry. 1999 Jul; 60(7):427-35. PMID: 10453795.
      View in: PubMed
    33. George MS, Tenebäck CC, Malcolm RJ, Moore J, Stallings LE, Spicer KM, Anton RF, Ballenger JC. Multiple previous alcohol detoxifications are associated with decreased medial temporal and paralimbic function in the postwithdrawal period. Alcohol Clin Exp Res. 1999 Jun; 23(6):1077-84. PMID: 10397294.
      View in: PubMed
    34. Emmanuel NP, Ware MR, Brawman-Mintzer O, Ballenger JC, Lydiard RB. Once-weekly dosing of fluoxetine in the maintenance of remission in panic disorder. J Clin Psychiatry. 1999 May; 60(5):299-301. PMID: 10362436.
      View in: PubMed
    35. Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Goldberg D, Magruder KM, Schulberg HC, Tylee A, Wittchen HU. Consensus statement on the primary care management of depression from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry. 1999; 60 Suppl 7:54-61. PMID: 10326875.
      View in: PubMed
    36. Ballenger JC. Clinical guidelines for establishing remission in patients with depression and anxiety. J Clin Psychiatry. 1999; 60 Suppl 22:29-34. PMID: 10634353.
      View in: PubMed
    37. Lorberbaum JP, Newman JD, Dubno JR, Horwitz AR, Nahas Z, Teneback CC, Bloomer CW, Bohning DE, Vincent D, Johnson MR, Emmanuel N, Brawman-Mintzer O, Book SW, Lydiard RB, Ballenger JC, George MS. Feasibility of using fMRI to study mothers responding to infant cries. Depress Anxiety. 1999; 10(3):99-104. PMID: 10604082.
      View in: PubMed
    38. Ballenger JC. Translational implications of the amygdala-stria terminalis model for the clinical anxiety disorders. Biol Psychiatry. 1998 Dec 15; 44(12):1204-7. PMID: 9861462.
      View in: PubMed
    39. Labbate LA, Johnson MR, Lydiard RB, Brawman-Mintzer O, Emmanuel N, Crawford M, Kapp R, Ballenger JC. Sleep Deprivation in social phobia and generalized anxiety disorder. Biol Psychiatry. 1998 Jun 01; 43(11):840-2. PMID: 9611674.
      View in: PubMed
    40. Ballenger JC. Comorbidity of panic and depression: implications for clinical management. Int Clin Psychopharmacol. 1998 Apr; 13 Suppl 4:S13-7. PMID: 9690960.
      View in: PubMed
    41. Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Baldwin DS, den Boer JA, Kasper S, Shear MK. Consensus statement on panic disorder from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry. 1998; 59 Suppl 8:47-54. PMID: 9707162.
      View in: PubMed
    42. Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Bobes J, Beidel DC, Ono Y, Westenberg HG. Consensus statement on social anxiety disorder from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry. 1998; 59 Suppl 17:54-60. PMID: 9811431.
      View in: PubMed
    43. Ballenger JC, Wheadon DE, Steiner M, Bushnell W, Gergel IP. Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder. Am J Psychiatry. 1998 Jan; 155(1):36-42. PMID: 9433336.
      View in: PubMed
    44. Ballenger JC. Treatment of panic disorder in the general medical setting. J Psychosom Res. 1998 Jan; 44(1):5-15. PMID: 9483459.
      View in: PubMed
    45. Labbate LA, Johnson MR, Lydiard RB, Brawman-Mintzer O, Emmanuel N, Crawford M, Kapp R, Ballenger JC. Sleep deprivation in panic disorder and obsessive-compulsive disorder. Can J Psychiatry. 1997 Nov; 42(9):982-3. PMID: 9429072.
      View in: PubMed
    46. Hollifield M, Katon W, Skipper B, Chapman T, Ballenger JC, Mannuzza S, Fyer AJ. Panic disorder and quality of life: variables predictive of functional impairment. Am J Psychiatry. 1997 Jun; 154(6):766-72. PMID: 9167503.
      View in: PubMed
    47. Brawman-Mintzer O, Lydiard RB, Bradwejn J, Villarreal G, Knapp R, Emmanuel N, Ware MR, He Q, Ballenger JC. Effects of the cholecystokinin agonist pentagastrin in patients with generalized anxiety disorder. Am J Psychiatry. 1997 May; 154(5):700-2. PMID: 9137133.
      View in: PubMed
    48. Ballenger JC. Discussion and overview: what can we learn if we view panic disorder across the life span and across different presentations and contexts? Bull Menninger Clin. 1997; 61(2 Suppl A):A95-102. PMID: 9149467.
      View in: PubMed
    49. Ballenger JC. Panic disorder in the medical setting. J Clin Psychiatry. 1997; 58 Suppl 2:13-7; discussion 18-9. PMID: 9078989.
      View in: PubMed
    50. Lydiard RB, Ballenger JC, Rickels K. A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group. J Clin Psychiatry. 1997; 58 Suppl 11:11-8. PMID: 9363043.
      View in: PubMed
    51. Irwin C, Falsetti SA, Lydiard RB, Ballenger JC, Brock CD, Brener W. Comorbidity of posttraumatic stress disorder and irritable bowel syndrome. J Clin Psychiatry. 1996 Dec; 57(12):576-8. PMID: 9010120.
      View in: PubMed
    52. Lydiard RB, Brawman-Mintzer O, Ballenger JC. Recent developments in the psychopharmacology of anxiety disorders. J Consult Clin Psychol. 1996 Aug; 64(4):660-8. PMID: 8803355.
      View in: PubMed
    53. Ballenger JC. Clinical evaluation of venlafaxine. J Clin Psychopharmacol. 1996 Jun; 16(3 Suppl 2):29S-35S; discussion 35S-36S. PMID: 8784646.
      View in: PubMed
    54. Fossey MD, Lydiard RB, Ballenger JC, Laraia MT, Bissette G, Nemeroff CB. Cerebrospinal fluid corticotropin-releasing factor concentrations in patients with anxiety disorders and normal comparison subjects. Biol Psychiatry. 1996 Apr 15; 39(8):703-7. PMID: 8731457.
      View in: PubMed
    55. Fyer AJ, Katon W, Hollifield M, Rassnick H, Mannuzza S, Chapman T, Ballenger JC. The DSM-IV panic disorder field trial: panic attack frequency and functional disability. Anxiety. 1996; 2(4):157-66. PMID: 9160617.
      View in: PubMed
    56. Katschnig H, Amering M, Stolk JM, Ballenger JC. Predictors of quality of life in a long-term followup study in panic disorder patients after a clinical drug trial. Psychopharmacol Bull. 1996; 32(1):149-55. PMID: 8927665.
      View in: PubMed
    57. Brawman-Mintzer O, Lydiard RB, Phillips KA, Morton A, Czepowicz V, Emmanuel N, Villareal G, Johnson M, Ballenger JC. Body dysmorphic disorder in patients with anxiety disorders and major depression: a comorbidity study. Am J Psychiatry. 1995 Nov; 152(11):1665-7. PMID: 7485632.
      View in: PubMed
    58. Czepowicz VD, Johnson MR, Lydiard RB, Emmanuel NP, Ware MR, Mintzer OB, Walsh MD, Ballenger JC. Sertraline in social phobia. J Clin Psychopharmacol. 1995 Oct; 15(5):372-3. PMID: 8830070.
      View in: PubMed
    59. Katschnig H, Amering M, Stolk JM, Klerman GL, Ballenger JC, Briggs A, Buller R, Cassano G, Garvey M, Roth M, et al. Long-term follow-up after a drug trial for panic disorder. Br J Psychiatry. 1995 Oct; 167(4):487-94. PMID: 8829718.
      View in: PubMed
    60. Kramer MS, Cutler NR, Ballenger JC, Patterson WM, Mendels J, Chenault A, Shrivastava R, Matzura-Wolfe D, Lines C, Reines S. A placebo-controlled trial of L-365,260, a CCKB antagonist, in panic disorder. Biol Psychiatry. 1995 Apr 01; 37(7):462-6. PMID: 7786960.
      View in: PubMed
    61. Brewerton TD, Zealberg JJ, Lydiard RB, Glover V, Sandler M, Ballenger JC. CSF isatin is elevated in bulimia nervosa. Biol Psychiatry. 1995 Apr 01; 37(7):481-3. PMID: 7786964.
      View in: PubMed
    62. Johnson MR, Lydiard RB, Ballenger JC. Panic disorder. Pathophysiology and drug treatment. Drugs. 1995 Mar; 49(3):328-44. PMID: 7774510.
      View in: PubMed
    63. Katon W, Hollifield M, Chapman T, Mannuzza S, Ballenger J, Fyer A. Infrequent panic attacks: psychiatric comorbidity, personality characteristics and functional disability. J Psychiatr Res. 1995 Mar-Apr; 29(2):121-31. PMID: 7666380.
      View in: PubMed
    64. Brady KT, Sonne SC, Anton R, Ballenger JC. Valproate in the treatment of acute bipolar affective episodes complicated by substance abuse: a pilot study. J Clin Psychiatry. 1995 Mar; 56(3):118-21. PMID: 7883730.
      View in: PubMed
    65. Brewerton TD, Lydiard RB, Herzog DB, Brotman AW, O'Neil PM, Ballenger JC. Comorbidity of axis I psychiatric disorders in bulimia nervosa. J Clin Psychiatry. 1995 Feb; 56(2):77-80. PMID: 7852257.
      View in: PubMed
    66. Emmanuel NP, Lydiard RB, Reynolds RD, Roberts J, Johnson M, Mintzer O, Ballenger JC. Plasma pyridoxal phosphate in anxiety disorders. Biol Psychiatry. 1994 Nov 01; 36(9):606-8. PMID: 7833426.
      View in: PubMed
    67. Johnson MR, Lydiard RB, Zealberg JJ, Fossey MD, Ballenger JC. Plasma and CSF HVA levels in panic patients with comorbid social phobia. Biol Psychiatry. 1994 Sep 15; 36(6):425-7. PMID: 7803603.
      View in: PubMed
    68. Santos AB, Ballenger JC, Bevilacqua JJ, Zealberg JJ, Hiers TG, McLeod-Bryant S, Deci PA, Rames LJ. A community-based public-academic liaison program. Am J Psychiatry. 1994 Aug; 151(8):1181-7. PMID: 8037253.
      View in: PubMed
    69. Brawman-Mintzer O, Lydiard RB, Crawford MM, Emmanuel N, Payeur R, Johnson M, Knapp RG, Ballenger JC. Somatic symptoms in generalized anxiety disorder with and without comorbid psychiatric disorders. Am J Psychiatry. 1994 Jun; 151(6):930-2. PMID: 8185009.
      View in: PubMed
    70. Woodman CL, Noyes R, Ballenger JC, Lydiard RB, Sievers G, Mihalko D. Predictors of response to alprazolam and placebo in patients with panic disorder. J Affect Disord. 1994 Jan; 30(1):5-13. PMID: 8151049.
      View in: PubMed
    71. Ballenger JC. Overview of panic disorder. Trans Am Clin Climatol Assoc. 1994; 105:36-51; discussion 51-3. PMID: 7974976.
      View in: PubMed
    72. Lydiard RB, Greenwald S, Weissman MM, Johnson J, Drossman DA, Ballenger JC. Panic disorder and gastrointestinal symptoms: findings from the NIMH Epidemiologic Catchment Area project. Am J Psychiatry. 1994 Jan; 151(1):64-70. PMID: 8267136.
      View in: PubMed
    73. Ballenger JC, Pecknold J, Rickels K, Sellers EM. Medication discontinuation in panic disorder. J Clin Psychiatry. 1993 Oct; 54 Suppl:15-21; discussion 22-4. PMID: 8262887.
      View in: PubMed
    74. Brawman-Mintzer O, Lydiard RB, Emmanuel N, Payeur R, Johnson M, Roberts J, Jarrell MP, Ballenger JC. Psychiatric comorbidity in patients with generalized anxiety disorder. Am J Psychiatry. 1993 Aug; 150(8):1216-8. PMID: 8328567.
      View in: PubMed
    75. Lydiard RB, Brewerton TD, Fossey MD, Laraia MT, Stuart G, Beinfeld MC, Ballenger JC. CSF cholecystokinin octapeptide in patients with bulimia nervosa and in normal comparison subjects. Am J Psychiatry. 1993 Jul; 150(7):1099-101. PMID: 8317583.
      View in: PubMed
    76. Laird LK, Lydiard RB, Morton WA, Steele TE, Kellner C, Thompson NM, Ballenger JC. Cardiovascular effects of imipramine, fluvoxamine, and placebo in depressed outpatients. J Clin Psychiatry. 1993 Jun; 54(6):224-8. PMID: 8331091.
      View in: PubMed
    77. Spiegel DA, Roth M, Weissman M, Lavori P, Gorman J, Rush J, Ballenger J. Comment on the London/Toronto Study of Alprazolam and Exposure in Panic Disorder with Agoraphobia. Br J Psychiatry. 1993 Jun; 162:788-9; discussion 790-4. PMID: 8101127.
      View in: PubMed
    78. Lydiard RB, Fossey MD, Marsh W, Ballenger JC. Prevalence of psychiatric disorders in patients with irritable bowel syndrome. Psychosomatics. 1993 May-Jun; 34(3):229-34. PMID: 8493304.
      View in: PubMed
    79. Johnson MR, Lydiard RB, Morton WA, Laird LK, Steele TE, Kellner CH, Ballenger JC. Effect of fluvoxamine, imipramine and placebo on catecholamine function in depressed outpatients. J Psychiatr Res. 1993 Apr-Jun; 27(2):161-72. PMID: 8396179.
      View in: PubMed
    80. Stuart G, Laraia MT, Ballenger JC. Attending nurses. J Child Adolesc Psychiatr Ment Health Nurs. 1993 Apr-Jun; 6(2):38. PMID: 8340905.
      View in: PubMed
    81. Ballenger JC, Fyer AJ. Examining criteria for panic disorder. Hosp Community Psychiatry. 1993 Mar; 44(3):226-8. PMID: 8444431.
      View in: PubMed
    82. Ballenger JC. Panic disorder: efficacy of current treatments. Psychopharmacol Bull. 1993; 29(4):477-86. PMID: 8084979.
      View in: PubMed
    83. Fossey MD, Lydiard RB, Ballenger JC, Laraia MT, Bissette G, Nemeroff CB. Cerebrospinal fluid thyrotropin-releasing hormone concentrations in patients with anxiety disorders. J Neuropsychiatry Clin Neurosci. 1993; 5(3):335-7. PMID: 8369645.
      View in: PubMed
    84. Brewerton TD, Lydiard RB, Ballenger JC, Herzog DB. Eating disorders and social phobia. Arch Gen Psychiatry. 1993 Jan; 50(1):70. PMID: 8481194.
      View in: PubMed
    85. Lydiard RB, Morton WA, Emmanuel NP, Zealberg JJ, Laraia MT, Stuart GW, O'Neil PM, Ballenger JC. Preliminary report: placebo-controlled, double-blind study of the clinical and metabolic effects of desipramine in panic disorder. Psychopharmacol Bull. 1993; 29(2):183-8. PMID: 8290663.
      View in: PubMed
    86. Lesser IM, Lydiard RB, Antal E, Rubin RT, Ballenger JC, DuPont R. Alprazolam plasma concentrations and treatment response in panic disorder and agoraphobia. Am J Psychiatry. 1992 Nov; 149(11):1556-62. PMID: 1415824.
      View in: PubMed
    87. Payeur R, Lydiard RB, Ballenger JC, Laraia MT, Fossey MD, Zealberg J. CSF diazepam-binding inhibitor concentrations in panic disorder. Biol Psychiatry. 1992 Oct 15; 32(8):712-6. PMID: 1333825.
      View in: PubMed
    88. DuPont RL, Swinson RP, Ballenger JC, Burrows GD, Noyes R, Rubin RT, Rifkin A, Pecknold JC. Discontinuation of alprazolam after long-term treatment of panic-related disorders. J Clin Psychopharmacol. 1992 Oct; 12(5):352-4. PMID: 1479053.
      View in: PubMed
    89. Santos AB, Ballenger JC. Tricyclic antidepressant triggers mania in patient with organic affective disorder. J Clin Psychiatry. 1992 Oct; 53(10):377-8. PMID: 1429478.
      View in: PubMed
    90. Brewerton TD, Lydiard RB, Laraia MT, Shook JE, Ballenger JC. CSF beta-endorphin and dynorphin in bulimia nervosa. Am J Psychiatry. 1992 Aug; 149(8):1086-90. PMID: 1353317.
      View in: PubMed
    91. Villeponteaux VA, Lydiard RB, Laraia MT, Stuart GW, Ballenger JC. The effects of pregnancy on preexisting panic disorder. J Clin Psychiatry. 1992 Jun; 53(6):201-3. PMID: 1607348.
      View in: PubMed
    92. Lydiard RB, Ballenger JC, Laraia MT, Fossey MD, Beinfeld MC. CSF cholecystokinin concentrations in patients with panic disorder and in normal comparison subjects. Am J Psychiatry. 1992 May; 149(5):691-3. PMID: 1575262.
      View in: PubMed
    93. Lydiard RB, Lesser IM, Ballenger JC, Rubin RT, Laraia M, DuPont R. A fixed-dose study of alprazolam 2 mg, alprazolam 6 mg, and placebo in panic disorder. J Clin Psychopharmacol. 1992 Apr; 12(2):96-103. PMID: 1573046.
      View in: PubMed
    94. Ballenger JC. Medication discontinuation in panic disorder. J Clin Psychiatry. 1992 Mar; 53 Suppl:26-31. PMID: 1548252.
      View in: PubMed
    95. Emmanuel NP, Lydiard RB, Ballenger JC. Blood groups in panic disorder. Am J Psychiatry. 1992 Mar; 149(3):410. PMID: 1536283.
      View in: PubMed
    96. Jolley R, Lydiard RB, Assey ME, Usher BW, Barnwell WH, Ballenger JC. Cardiovascular status of panic disorder patients with and without prominent cardiac symptoms. Psychosomatics. 1992; 33(1):81-4. PMID: 1539107.
      View in: PubMed
    97. Ballenger JC, McDonald S, Noyes R, Rickels K, Woods SW, Patin J, Lydiard B, Garvey M, Cook B, Goodard AW, et al. The first double-blind, placebo-controlled trial of a partial benzodiazepine agonist, abecarnil (ZK 112-119), in generalized anxiety disorder. Adv Biochem Psychopharmacol. 1992; 47:431-47. PMID: 1354920.
      View in: PubMed
    98. Brady KT, Lydiard RB, Malcolm R, Ballenger JC. Cocaine-induced psychosis. J Clin Psychiatry. 1991 Dec; 52(12):509-12. PMID: 1752853.
      View in: PubMed
    99. Lydiard RB, Fossey MD, Ballenger JC. Irritable bowel syndrome in patients with panic disorder. Am J Psychiatry. 1991 Nov; 148(11):1614. PMID: 1928500.
      View in: PubMed
    100. Brady KT, Lydiard RB, Ballenger JC, Shook J, Laraia M, Fossey M. CSF opioids in panic disorder. Biol Psychiatry. 1991 Sep 01; 30(5):512-4. PMID: 1681945.
      View in: PubMed
    101. Austin LS, Lydiard RB, Ballenger JC, Cohen BM, Laraia MT, Zealberg JJ, Fossey MD, Ellinwood EH. Dopamine blocking activity of clomipramine in patients with obsessive-compulsive disorder. Biol Psychiatry. 1991 Aug 01; 30(3):225-32. PMID: 1832972.
      View in: PubMed
    102. Emmanuel NP, Lydiard RB, Ballenger JC. Treatment of social phobia with bupropion. J Clin Psychopharmacol. 1991 Aug; 11(4):276-7. PMID: 1918431.
      View in: PubMed
    103. Emmanuel NP, Lydiard RB, Ballenger JC. Fluoxetine treatment of voyeurism. Am J Psychiatry. 1991 Jul; 148(7):950. PMID: 2053642.
      View in: PubMed
    104. Melvin JA, Lydiard RB, Crowe CM, Laraia MT, Fossey MD, Ballenger JC. Effect of alprazolam on depression in panic disorder. J Clin Psychopharmacol. 1991 Apr; 11(2):145-6. PMID: 2056142.
      View in: PubMed
    105. Schatzberg AF, Ballenger JC. Decisions for the clinician in the treatment of panic disorder: when to treat, which treatment to use, and how long to treat. J Clin Psychiatry. 1991 Feb; 52 Suppl:26-31; discussion 32. PMID: 1995599.
      View in: PubMed
    106. Ballenger JC. Long-term pharmacologic treatment of panic disorder. J Clin Psychiatry. 1991 Feb; 52 Suppl:18-23; discussion 24-5. PMID: 1995598.
      View in: PubMed
    107. Kellner CH, Jolley RR, Holgate RC, Austin L, Lydiard RB, Laraia M, Ballenger JC. Brain MRI in obsessive-compulsive disorder. Psychiatry Res. 1991 Jan; 36(1):45-9. PMID: 2017522.
      View in: PubMed
    108. Malcolm R, Hutto BR, Phillips JD, Ballenger JC. Pergolide mesylate treatment of cocaine withdrawal. J Clin Psychiatry. 1991 Jan; 52(1):39-40. PMID: 1988417.
      View in: PubMed
    109. Ballenger JC, McDonald S, Noyes R, Rickels K, Sussman N, Woods S, Patin J, Singer J. The first double-blind, placebo-controlled trial of a partial benzodiazepine agonist abecarnil (ZK 112-119) in generalized anxiety disorder. Psychopharmacol Bull. 1991; 27(2):171-9. PMID: 1681563.
      View in: PubMed
    110. Zealberg JJ, Santos AB, Hiers TG, Ballenger JC, Puckett JA, Christie SD. From the benches to the trenches : training residents to provide emergency outreach services-a public/academic project. Acad Psychiatry. 1990 Dec; 14(4):211-7. PMID: 24436102.
      View in: PubMed
    111. Austin LS, Lydiard RB, Fossey MD, Zealberg JJ, Laraia MT, Ballenger JC. Panic and phobic disorders in patients with obsessive compulsive disorder. J Clin Psychiatry. 1990 Nov; 51(11):456-8. PMID: 2228980.
      View in: PubMed
    112. Brady K, Anton R, Ballenger JC, Lydiard RB, Adinoff B, Selander J. Cocaine abuse among schizophrenic patients. Am J Psychiatry. 1990 Sep; 147(9):1164-7. PMID: 2386250.
      View in: PubMed
    113. Austin LS, Arana GW, Ballenger JC. Rapid response of patients simultaneously treated with lithium and nortriptyline. J Clin Psychiatry. 1990 Mar; 51(3):124-5. PMID: 2407731.
      View in: PubMed
    114. Stuart GW, Laraia MT, Ballenger JC, Lydiard RB. Early family experiences of women with bulimia and depression. Arch Psychiatr Nurs. 1990 Feb; 4(1):43-52. PMID: 2317098.
      View in: PubMed
    115. Kaye WH, Ballenger JC, Lydiard RB, Stuart GW, Laraia MT, O'Neil P, Fossey MD, Stevens V, Lesser S, Hsu G. CSF monoamine levels in normal-weight bulimia: evidence for abnormal noradrenergic activity. Am J Psychiatry. 1990 Feb; 147(2):225-9. PMID: 1689122.
      View in: PubMed
    116. Rifkin A, Pecknold JC, Swinson RP, Ballenger JC, Burrows GD, Noyes R, Dupont RL, Lesser I. Sequence of improvement in agoraphobia with panic attacks. J Psychiatr Res. 1990; 24(1):1-8. PMID: 2195163.
      View in: PubMed
    117. Ballenger JC. Efficacy of benzodiazepines in panic disorder and agoraphobia. J Psychiatr Res. 1990; 24 Suppl 2:15-25. PMID: 1980694.
      View in: PubMed
    118. Lydiard RB, Laraia MT, Howell EF, Fossey MD, Reynolds RD, Ballenger JC. Phenelzine treatment of panic disorder: lack of effect on pyridoxal phosphate levels. J Clin Psychopharmacol. 1989 Dec; 9(6):428-31. PMID: 2687338.
      View in: PubMed
    119. Lydiard RB, Howell EF, Laraia MT, Fossey MD, Ballenger JC. Depression in patients receiving lorazepam for panic. Am J Psychiatry. 1989 Sep; 146(9):1230-1. PMID: 2764184.
      View in: PubMed
    120. Arana GW, Santos AB, Knax EP, Ballenger JC. Refractory rapid cycling unipolar depression responds to lithium and carbamazepine treatment. J Clin Psychiatry. 1989 Sep; 50(9):356-7. PMID: 2768205.
      View in: PubMed
    121. Ballenger JC, Carek DJ, Steele JJ, Cornish-McTighe D. Three cases of panic disorder with agoraphobia in children. Am J Psychiatry. 1989 Jul; 146(7):922-4. PMID: 2742019.
      View in: PubMed
    122. Anton RF, Ballenger JC, Lydiard RB, Laraia MT, Howell EF, Gold PW. CSF prostaglandin-E in agoraphobia with panic attacks. Biol Psychiatry. 1989 Jul; 26(3):257-64. PMID: 2545288.
      View in: PubMed
    123. Malcolm R, Ballenger JC, Sturgis ET, Anton R. Double-blind controlled trial comparing carbamazepine to oxazepam treatment of alcohol withdrawal. Am J Psychiatry. 1989 May; 146(5):617-21. PMID: 2653057.
      View in: PubMed
    124. Ballenger JC. Toward an integrated model of panic disorder. Am J Orthopsychiatry. 1989 Apr; 59(2):284-93. PMID: 2653050.
      View in: PubMed
    125. Lydiard RB, Laird LK, Morton WA, Steele TE, Kellner C, Laraia MT, Ballenger JC. Fluvoxamine, imipramine, and placebo in the treatment of depressed outpatients: effects on depression. Psychopharmacol Bull. 1989; 25(1):68-70. PMID: 2505304.
      View in: PubMed
    126. Lesser IM, Rubin RT, Rifkin A, Swinson RP, Ballenger JC, Burrows GD, Dupont RL, Noyes R, Pecknold JC. Secondary depression in panic disorder and agoraphobia. II. Dimensions of depressive symptomatology and their response to treatment. J Affect Disord. 1989 Jan-Feb; 16(1):49-58. PMID: 2521651.
      View in: PubMed
    127. Lydiard RB, Zealberg J, Laraia MT, Fossey M, Prockow V, Gross J, Ballenger JC. Electroencephalography during sleep of patients with panic disorder. J Neuropsychiatry Clin Neurosci. 1989; 1(4):372-6. PMID: 2521085.
      View in: PubMed
    128. Ballenger JC. The use of anticonvulsants in manic-depressive illness. J Clin Psychiatry. 1988 Nov; 49 Suppl:21-5. PMID: 3053672.
      View in: PubMed
    129. Lydiard RB, Roy-Byrne PP, Ballenger JC. Recent advances in the psychopharmacological treatment of anxiety disorders. Hosp Community Psychiatry. 1988 Nov; 39(11):1157-65. PMID: 2906319.
      View in: PubMed
    130. Lydiard RB, Laraia MT, Fossey M, Ballenger JC. Possible relationship of bowel obsessions to panic disorder with agoraphobia. Am J Psychiatry. 1988 Oct; 145(10):1324-5. PMID: 3421372.
      View in: PubMed
    131. Santos AB, Thrasher JW, Ballenger JC. Decentralized services for public hospital patients: a cost analysis. Hosp Community Psychiatry. 1988 Aug; 39(8):827-9. PMID: 3209197.
      View in: PubMed
    132. Cox DJ, Ballenger JC, Laraia M, Hobbs WR, Peterson GA, Hucek A. Different rates of improvement of different symptoms in combined pharmacological and behavioral treatment of agoraphobia. J Behav Ther Exp Psychiatry. 1988 Jun; 19(2):119-26. PMID: 3209696.
      View in: PubMed
    133. Ballenger JC, Burrows GD, DuPont RL, Lesser IM, Noyes R, Pecknold JC, Rifkin A, Swinson RP. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment. Arch Gen Psychiatry. 1988 May; 45(5):413-22. PMID: 3282478.
      View in: PubMed
    134. Noyes R, DuPont RL, Pecknold JC, Rifkin A, Rubin RT, Swinson RP, Ballenger JC, Burrows GD. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety. Arch Gen Psychiatry. 1988 May; 45(5):423-8. PMID: 3358644.
      View in: PubMed
    135. Ballenger JC. The clinical use of carbamazepine in affective disorders. J Clin Psychiatry. 1988 Apr; 49 Suppl:13-21. PMID: 3280557.
      View in: PubMed
    136. Brown ME, Anton RF, Malcolm R, Ballenger JC. Alcohol detoxification and withdrawal seizures: clinical support for a kindling hypothesis. Biol Psychiatry. 1988 Mar 01; 23(5):507-14. PMID: 3345323.
      View in: PubMed
    137. Lydiard RB, Brady KT, O'Neil PM, Schlesier-Carter B, Hamilton S, Rogers Q, Ballenger JC. Precursor amino acid concentrations in normal weight bulimics and normal controls. Prog Neuropsychopharmacol Biol Psychiatry. 1988; 12(6):893-8. PMID: 3241872.
      View in: PubMed
    138. Lydiard RB, Laraia MT, Howell EF, Ballenger JC. Alprazolam in the treatment of social phobia. J Clin Psychiatry. 1988 Jan; 49(1):17-9. PMID: 3335485.
      View in: PubMed
    139. Ballenger JC. Unrecognized prevalence of panic disorder in primary care, internal medicine and cardiology. Am J Cardiol. 1987 Dec 28; 60(18):39J-47J. PMID: 3321969.
      View in: PubMed
    140. Lydiard RB, Ballenger JC. Antidepressants in panic disorder and agoraphobia. J Affect Disord. 1987 Sep-Oct; 13(2):153-68. PMID: 2960710.
      View in: PubMed
    141. Lydiard RB, Laraia MT, Ballenger JC, Howell EF. Emergence of depressive symptoms in patients receiving alprazolam for panic disorder. Am J Psychiatry. 1987 May; 144(5):664-5. PMID: 3578580.
      View in: PubMed
    142. Lydiard RB, Howell EF, Laraia MT, Ballenger JC. Sexual side effects of alprazolam. Am J Psychiatry. 1987 Feb; 144(2):254-5. PMID: 3812806.
      View in: PubMed
    143. Lydiard RB, Laraia MT, Howell EF, Ballenger JC. Can panic disorder present as irritable bowel syndrome? J Clin Psychiatry. 1986 Sep; 47(9):470-3. PMID: 3745130.
      View in: PubMed
    144. Post RM, Rubinow DR, Ballenger JC. Conditioning and sensitisation in the longitudinal course of affective illness. Br J Psychiatry. 1986 Aug; 149:191-201. PMID: 3535979.
      View in: PubMed
    145. Ballenger JC. Pharmacotherapy of the panic disorders. J Clin Psychiatry. 1986 Jun; 47 Suppl:27-32. PMID: 2872207.
      View in: PubMed
    146. Joffe RT, Post RM, Ballenger JC, Rebar R, Gold PW. The effects of lithium on neuroendocrine function in affectively ill patients. Acta Psychiatr Scand. 1986 May; 73(5):524-8. PMID: 3092580.
      View in: PubMed
    147. Ballenger JC. Biological aspects of panic disorder. Am J Psychiatry. 1986 Apr; 143(4):516-8. PMID: 3953894.
      View in: PubMed
    148. Post RM, Rubinow DR, Uhde TW, Ballenger JC, Linnoila M. Dopaminergic effects of carbamazepine. Relationship to clinical response in affective illness. Arch Gen Psychiatry. 1986 Apr; 43(4):392-6. PMID: 3954558.
      View in: PubMed
    149. Joffe RT, Post RM, Ballenger JC, Rebar R, Gold PW. Neuroendocrine effects of carbamazepine in patients with affective illness. Epilepsia. 1986 Mar-Apr; 27(2):156-60. PMID: 3082622.
      View in: PubMed
    150. Joffe RT, Post RM, Ballenger JC, Rebar R, Rakita R, Gold PW. Neuroendocrine effects of the dopamine agonist piribedil in depressed patients. Clin Neuropharmacol. 1986; 9(5):448-55. PMID: 3768867.
      View in: PubMed
    151. Peterson GA, Ballenger JC, Cox DP, Hucek A, Lydiard RB, Laraia MT, Trockman C. The dexamethasone suppression test in agoraphobia. J Clin Psychopharmacol. 1985 Apr; 5(2):100-2. PMID: 3988966.
      View in: PubMed
    152. Post RM, Rubinow DR, Uhde TW, Ballenger JC, Lake CR, Linnoila M, Jimerson DC, Reus V. Effects of carbamazepine on noradrenergic mechanisms in affectively ill patients. Psychopharmacology (Berl). 1985; 87(1):59-63. PMID: 2997829.
      View in: PubMed
    153. Rubinow DR, Gold PW, Post RM, Ballenger JC. CSF somatostatin in affective illness and normal volunteers. Prog Neuropsychopharmacol Biol Psychiatry. 1985; 9(4):393-400. PMID: 2866561.
      View in: PubMed
    154. Rubinow DR, Post RM, Gold PW, Ballenger JC, Reichlin S. Effects of carbamazepine on cerebrospinal fluid somatostatin. Psychopharmacology (Berl). 1985; 85(2):210-3. PMID: 2861620.
      View in: PubMed
    155. Ballenger JC. Psychopharmacology of the anxiety disorders. Psychiatr Clin North Am. 1984 Dec; 7(4):757-71. PMID: 6151647.
      View in: PubMed
    156. Vieweg WV, Yazel JJ, Ballenger JC. Tricyclic antidepressant use in a patient with bundle branch blocks and ventricular ectopy. J Clin Psychiatry. 1984 Aug; 45(8):353-5. PMID: 6204970.
      View in: PubMed
    157. Post RM, Uhde TW, Ballenger JC. The efficacy of carbamazepine in affective illness. Adv Biochem Psychopharmacol. 1984; 39:421-37. PMID: 6380232.
      View in: PubMed
    158. Ballenger JC, Post RM. Carbamazepine in alcohol withdrawal syndromes and schizophrenic psychoses. Psychopharmacol Bull. 1984; 20(3):572-84. PMID: 6382378.
      View in: PubMed
    159. Zuckerman M, Ballenger JC, Post RM. The neurobiology of some dimensions of personality. Int Rev Neurobiol. 1984; 25:391-436. PMID: 6469473.
      View in: PubMed
    160. Post RM, Uhde TW, Ballenger JC, Squillace KM. Prophylactic efficacy of carbamazepine in manic-depressive illness. Am J Psychiatry. 1983 Dec; 140(12):1602-4. PMID: 6139957.
      View in: PubMed
    161. Gold PW, Robertson GL, Ballenger JC, Kaye W, Chen J, Rubinow DR, Goodwin FK, Post RM. Carbamazepine diminishes the sensitivity of the plasma arginine vasopressin response to osmotic stimulation. J Clin Endocrinol Metab. 1983 Nov; 57(5):952-7. PMID: 6619270.
      View in: PubMed
    162. Kellner CH, Rakita RM, Rubinow DA, Gold PW, Ballenger JC, Post RM. Tetrahydrobiopterin levels in cerebrospinal fluid of affectively ill patients. Lancet. 1983 Jul 02; 2(8340):55-6. PMID: 6134926.
      View in: PubMed
    163. Sternberg DE, van Kammen DP, Lerner P, Ballenger JC, Marder SR, Post RM, Bunney WE. CSF dopamine beta-hydroxylase in schizophrenia. Arch Gen Psychiatry. 1983 Jul; 40(7):743-7. PMID: 6134515.
      View in: PubMed
    164. Post RM, Ballenger JC, Putnam FW, Bunney WE. Carbamazepine in alcohol withdrawal syndromes: relationship to the kindling model. J Clin Psychopharmacol. 1983 Jun; 3(3):204-5. PMID: 6875029.
      View in: PubMed
    165. Post RM, Uhde TW, Ballenger JC, Chatterji DC, Greene RF, Bunney WE. Carbamazepine and its -10,11-epoxide metabolite in plasma and CSF. Relationship to antidepressant response. Arch Gen Psychiatry. 1983 Jun; 40(6):673-6. PMID: 6847334.
      View in: PubMed
    166. Rubinow DR, Gold PW, Post RM, Ballenger JC, Cowdry R, Bollinger J, Reichlin S. CSF somatostatin in affective illness. Arch Gen Psychiatry. 1983 Apr; 40(4):409-12. PMID: 6132592.
      View in: PubMed
    167. Gold PW, Robertson GL, Post RM, Kaye W, Ballenger J, Rubinow D, Goodwin FK. The effect of lithium on the osmoregulation of arginine vasopressin secretion. J Clin Endocrinol Metab. 1983 Feb; 56(2):295-9. PMID: 6401749.
      View in: PubMed
    168. Rubinow DR, Gold PW, Post RM, Ballenger JC, Reichlin S. Cerebrospinal fluid somatostatin in primary affective disorder. Psychopharmacol Bull. 1983; 19(3):422-5. PMID: 6138797.
      View in: PubMed
    169. Post RM, Uhde TW, Rubinow DR, Ballenger JC, Gold PW. Biochemical effects of carbamazepine: relationship to its mechanisms of action in affective illness. Prog Neuropsychopharmacol Biol Psychiatry. 1983; 7(2-3):263-71. PMID: 6137029.
      View in: PubMed
    170. Gold PW, Robertson GL, Ballenger JC, Goodwin FK, Rubinow DR, Kellner C, Post RM. Neurohypophyseal function in affective illness. Psychopharmacol Bull. 1983; 19(3):426-31. PMID: 6635117.
      View in: PubMed
    171. Post RM, Uhde TW, Putnam FW, Ballenger JC, Berrettini WH. Kindling and carbamazepine in affective illness. J Nerv Ment Dis. 1982 Dec; 170(12):717-31. PMID: 6754868.
      View in: PubMed
    172. Shemo JP, Ballenger JC, Yazel JJ, Spradlin WW. A conjoint psychiatry-internal medicine program: development of a teaching and clinical model. Am J Psychiatry. 1982 Nov; 139(11):1437-42. PMID: 7137393.
      View in: PubMed
    173. Post RM, Ballenger JC, Uhde TW, Smith C, Rubinow DR, Bunney WE. Effect of carbamazepine on cyclic nucleotides in CSF of patients with affective illness. Biol Psychiatry. 1982 Sep; 17(9):1037-45. PMID: 6291645.
      View in: PubMed
    174. Post RM, Gold P, Rubinow DR, Ballenger JC, Bunney WE, Goodwin FK. Peptides in the cerebrospinal fluid of neuropsychiatric patients: an approach to central nervous system peptide function. Life Sci. 1982 Jul 05; 31(1):1-15. PMID: 6180277.
      View in: PubMed
    175. Ballenger JC, Reus VI, Post RM. The "atypical" clinical picture of adolescent mania. Am J Psychiatry. 1982 May; 139(5):602-6. PMID: 7072845.
      View in: PubMed
    176. Hare TA, Wood JH, Manyam BV, Gerner RH, Ballenger JC, Post RM. Central nervous system gamma-aminobutyric acid activity in man. Relationship to age and sex as reflected in CSF. Arch Neurol. 1982 Apr; 39(4):247-9. PMID: 7073535.
      View in: PubMed
    177. Garbutt JC, van Kammen DP, Levine RA, Sternberg DE, Murphy DL, Ballenger J, Bunney WE, Lovenberg WM. Cerebrospinal fluid hydroxylase cofactor in schizophrenia. Psychiatry Res. 1982 Apr; 6(2):145-51. PMID: 6953456.
      View in: PubMed
    178. Pickar D, Naber D, Post RM, van Kammen DP, Kaye W, Rubinow DR, Ballenger JC, Bunney WE. Endorphins in the cerebrospinal fluid of psychiatric patients. Ann N Y Acad Sci. 1982; 398:399-412. PMID: 6297360.
      View in: PubMed
    179. Paul SM, Rehavi M, Skolnick P, Ballenger JC, Goodwin FK. Depressed patients have decreased binding of tritiated imipramine to platelet serotonin "transporter". Arch Gen Psychiatry. 1981 Dec; 38(12):1315-7. PMID: 7316676.
      View in: PubMed
    180. Naber D, Pickar D, Post RM, Van Kammen DP, Waters RN, Ballenger JC, Goodwin FK, Bunney WE. Endogenous opioid activity and beta-endorphin immunoreactivity in CSF of psychiatric patients and normal volunteers. Am J Psychiatry. 1981 Nov; 138(11):1457-62. PMID: 6271019.
      View in: PubMed
    181. Post RM, Pickar D, Naber D, Ballenger JC, Uhde TW, Bunney WE. Effect of carbamazepine on CSF opioid activity; relationship to antidepressant response. Psychiatry Res. 1981 Aug; 5(1):59-66. PMID: 6269141.
      View in: PubMed
    182. Rubinow DR, Post RM, Pickar D, Naber D, Ballenger JC, Gold PW, Bunney WE. Relationship between urinary free cortisol and CSF opioid binding activity in depressed patients and normal volunteers. Psychiatry Res. 1981 Aug; 5(1):87-93. PMID: 6269142.
      View in: PubMed
    183. Sternberg DE, van Kammen DP, Lake CR, Ballenger JC, Marder SR, Bunney WE. The effect of pimozide on CSF norepinephrine in schizophrenia. Am J Psychiatry. 1981 Aug; 138(8):1045-50. PMID: 7258379.
      View in: PubMed
    184. Post RM, Ballenger JC, Rey AC, Bunney WE. Slow and rapid onset of manic episodes: implications for underlying biology. Psychiatry Res. 1981 Apr; 4(2):229-37. PMID: 6939012.
      View in: PubMed
    185. Weingartner H, Gold P, Ballenger JC, Smallberg SA, Summers R, Rubinow DR, Post RM, Goodwin FK. Effects of vasopressin on human memory functions. Science. 1981 Feb 06; 211(4482):601-3. PMID: 7455701.
      View in: PubMed
    186. Jimerson DC, Ballenger JC, Lake CR, Post RM, Goodwin FK, Kopin IJ. Plasma and CSF MHPG in normals [proceedings]. Psychopharmacol Bull. 1981 Jan; 17(1):86-7. PMID: 7232666.
      View in: PubMed
    187. Pickar D, Naber D, Post RM, van Kammen DP, Ballenger J, Kalin N, Bunney WE. Measurement of endorphins in CSF. Relationship to psychiatric diagnosis. Mod Probl Pharmacopsychiatry. 1981; 17:246-62. PMID: 7329420.
      View in: PubMed
    188. Brown GL, Goodwin FK, Ballenger JC, Goyer PF. Cerebrospinal fluid amine metabolites and cyclic nucleotides in human aggression [proceedings]. Psychopharmacol Bull. 1981 Jan; 17(1):63-5. PMID: 6165032.
      View in: PubMed
    189. Post RM, Ballenger JC, Hare TA, Bunney WE. Lack of effect of carbamazepine on gamma-aminobutyric acid in cerebrospinal fluid. Neurology. 1980 Sep; 30(9):1008-11. PMID: 7191529.
      View in: PubMed
    190. Becker KL, Silva OL, Post RM, Ballenger JC, Carman JS, Snider RH, Moore CF. Immunoreactive calcitonin in cerebrospinal fluid of man. Brain Res. 1980 Aug 04; 194(2):598-602. PMID: 7388636.
      View in: PubMed
    191. Ballenger JC, Post RM. Carbamazepine in manic-depressive illness: a new treatment. Am J Psychiatry. 1980 Jul; 137(7):782-90. PMID: 7386656.
      View in: PubMed
    192. Gold PW, Extein I, Ballenger JC, Wehr TA. Rapid mood cycling and concomitant cortisol changes produced by cyproheptadine. Am J Psychiatry. 1980 Mar; 137(3):378-9. PMID: 7356073.
      View in: PubMed
    193. Major LF, Lerner P, Goodwin FK, Ballenger JC, Brown GL, Lovenberg W. Dopamine beta-hydroxylase in CSF. Relationship to personality measures. Arch Gen Psychiatry. 1980 Mar; 37(3):308-10. PMID: 7362418.
      View in: PubMed
    194. Lake CR, Sternberg DE, van Kammen DP, Ballenger JC, Ziegler MG, Post RM, Kopin IJ, Bunney WE. Schizophrenia: elevated cerebrospinal fluid norepinephrine. Science. 1980 Jan 18; 207(4428):331-3. PMID: 7350667.
      View in: PubMed
    195. Sheehan DV, Ballenger J, Jacobsen G. Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms. Arch Gen Psychiatry. 1980 Jan; 37(1):51-9. PMID: 7352840.
      View in: PubMed
    196. Gold PW, Weingartner H, Ballenger JC, Goodwin FK, Post RM. Effects of 1-desamo-8-D-arginine vasopressin on behaviour and cognition in primary affective disorder. Lancet. 1979 Nov 10; 2(8150):992-4. PMID: 91778.
      View in: PubMed
    197. Brown GL, Goodwin FK, Ballenger JC, Goyer PF, Major LF. Aggression in humans correlates with cerebrospinal fluid amine metabolites. Psychiatry Res. 1979 Oct; 1(2):131-9. PMID: 95232.
      View in: PubMed
    198. Hare TA, Wood JH, Ballenger JC, Post RM. gamma-Aminobutyric acid in human cerebrospinal fluid: normal values. Lancet. 1979 Sep 08; 2(8141):534-5. PMID: 90262.
      View in: PubMed
    199. Wood JH, Hare TA, Glaeser BS, Ballenger JC, Post RM. Low cerebrospinal fluid gamma-aminobutyric acid content in seizure patients. Neurology. 1979 Sep; 29(9 Pt 1):1203-8. PMID: 113694.
      View in: PubMed
    200. Ballenger JC, Post RM, Sternberg DE, Van Kammen DP, Cowdry RW, Goodwin FK. Headaches after lumbar puncture and insensitivity to pain in psychiatric patients. N Engl J Med. 1979 Jul 12; 301(2):110. PMID: 449939.
      View in: PubMed
    201. Major LF, Lerner P, Ballenger JC, Brown GL, Goodwin FK, Lovenberg W. Dopamine-beta-hydroxylase in the cerebrospinal fluid: relationship to disulfiram-induced psychosis. Biol Psychiatry. 1979 Apr; 14(2):337-44. PMID: 476222.
      View in: PubMed
    202. Ballenger JC, Goodwin FK, Major LF, Brown GL. Alcohol and central serotonin metabolism in man. Arch Gen Psychiatry. 1979 Feb; 36(2):224-7. PMID: 420544.
      View in: PubMed
    203. Lerner P, Goodwin FK, van Kammen DP, Post RM, Major LF, Ballenger JC, Lovenberg W. Dopamine-beta-hydroxylase in the cerebrospinal fluid of psychiatric patients. Biol Psychiatry. 1978 Dec; 13(6):685-94. PMID: 737256.
      View in: PubMed
    204. Ballenger JC, Post RM. Kindling as a model for alcohol withdrawal syndromes. Br J Psychiatry. 1978 Jul; 133:1-14. PMID: 352467.
      View in: PubMed
    205. Ballenger JC, Post RM. Therapeutic effects of carbamazepine in affective illness: a preliminary report. Commun Psychopharmacol. 1978; 2(2):159-75. PMID: 352607.
      View in: PubMed
    206. Major LF, Ballenger JC, Goodwin FK, Brown GL. Cerebrospinal fluid homovanillic acid in male alcoholics: effects of disulfiram. Biol Psychiatry. 1977 Oct; 12(5):635-42. PMID: 588644.
      View in: PubMed
    207. Ballenger JC. Electroconvulsive therapy and cardiac pacemakers. Psychosomatics. 1973 Jul-Aug; 14(4):233-4. PMID: 4794928.
      View in: PubMed
    Ballenger's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description